Qpex Biopharma: Funding, Investors & Team (Oct 2026)
Qpex Biopharma specializes in developing a range of medications to address the urgent needs in treating infections. Their focus is on creating multiple antibiotics to combat the growing issue of antimicrobial resistance. The company's technology is dedicated to treating infectious diseases in both hospital and community settings. They have extensive experience in researching, developing, and gaining approval for anti-infective medications, and have a strong history of collaborating with public and private partnerships to create new antibiotics. This allows medical professionals to effectively use their products to meet the critical needs for treating infectious diseases. Founded in 2018, Qpex Biopharma is based in San Diego, California.
Qpex Biopharma has raised $10.0M across 1 funding round on record, the most recent an undisclosed round of $10.0M announced in May 2024.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Qpex Biopharma Company Profile and Key Stats
Latest funding round on record: May 2024.
Qpex Biopharma Funding Rounds
Qpex Biopharma Founders and Leadership Team
No contact details are on record for this team yet.
Qpex Biopharma Funding Compared to Other Biotechnology Startups
Qpex Biopharma's latest round of $10.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Qpex Biopharma in Biotechnology and San Diego
Companies Similar to Qpex Biopharma
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Qpex Biopharma Funding FAQs
What does Qpex Biopharma do?
Qpex Biopharma specializes in developing a range of medications to address the urgent needs in treating infections. Their focus is on creating multiple antibiotics to combat the growing issue of antimicrobial resistance. The company's technology is dedicated to treating infectious diseases in both hospital and community settings. They have extensive experience in researching, developing, and gaining approval for anti-infective medications, and have a strong history of collaborating with public and private partnerships to create new antibiotics. This allows medical professionals to effectively use their products to meet the critical needs for treating infectious diseases. Founded in 2018, Qpex Biopharma is based in San Diego, California.
How much funding has Qpex Biopharma raised?
Qpex Biopharma has raised $10.0M across 1 round on record. The most recent is an undisclosed round of $10.0M announced in May 2024.
When did Qpex Biopharma last raise funding?
Qpex Biopharma's most recent funding round on record is an undisclosed round of $10.0M, announced in May 2024.
Who founded Qpex Biopharma?
FundedIQ lists Michael Dudley (Founder) at Qpex Biopharma.
Where is Qpex Biopharma headquartered?
Qpex Biopharma is based in San Diego, California, United States.
How many employees does Qpex Biopharma have?
Qpex Biopharma is in the 11-50 employee band.
How does Qpex Biopharma's funding compare to other Biotechnology startups?
Qpex Biopharma's latest round of $10.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Qpex Biopharma Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Qpex Biopharma is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.